Vasculitis is an autoimmune disorder that causes inflammation of the blood vessels. It can affect arteries, veins, and capillaries. This condition causes blood vessel walls to swell, which restricts ...

The Latest Polymyalgia rheumatica is an inflammatory disorder ... Most people with an autoimmune disease can live a full, normal life. But some autoimmune diseases can affect your life expectancy ...

The researchers saw the strongest association for systemic autoimmune rheumatic diseases ... (temporal artery inflammation) and polymyalgia rheumatica (muscle pain and stiffness).

Susan had her initial consultation with the rheumatologist, who diagnosed Polymyalgia Rheumatica—a different type of autoimmune disease affecting the joints. He recommended she start Prednisone, which ...

Objectives Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are overlapping autoinflammatory diseases affecting people over 50 years. The diseases are treated with immunosuppressive drugs ...

In autoimmune diseases, the body’s immune system mistakenly attacks healthy tissues, causing inflammation and fatigue. Conditions like lupus, Sjögren’s syndrome, or polymyalgia rheumatica can ...

It targets key inflammatory pathways involved in autoimmune disease progression aiming to reduce ... of 2.69% during 2024-2034. Polymyalgia Rheumatica Market: The 7 major polymyalgia rheumatica ...

polymyalgia rheumatica, granulomatosis with polyangiitis, juvenile idiopathic arthritis, spondyloarthritis and undifferentiated connective tissue disease. Eight (12.1%) patients had autoimmune ...

autoimmune diseases outcome assessment health care inflammation ... polyangiitis), M351 (mixed CTD/overlap syndrome), M300 (polyarteritis nodosa), M352 (polymyalgia rheumatica (PMR)), M332 ...

Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting elderly people and involving the girdles. [1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR ...

The CHMP has recommended the approval of AbbVie's upadacitinib (Rinvoq) for treating adults with giant cell arteritis (GCA).